Current Pharmaceutical Situation (Services) in Yemen and Future Challenges

Hemophilia unfortunately a less attracted disease f or researchers compared to other life threatening diseases. The prevalence of hemophilia is estimated to be about 1:10,000 birth and that of the severe form of the disease to be ab out 6% per 1,00,000 population. The most pathetic part of this disease is that even medical personnel are sometimes not familiar with its diagnosis and management. There is obviously a need to establish facilities and treatment options that will help the patient with hemophilia to manage their life with ease. As this is a genetic disorder no complete cure is possible as of now. The only available treatment option is the infusion of factors and some adjuvant therap ies depending upon the bleeding conditions .The initiative for the development of new dosage f orms, new delivery systems of the existing therapies or new treatment options has to be driven by pharmacy professionals. This article present an overview of hemophilia, in order to drag the attention of medical as well as pharmacy professionals for the benefit of millions of hemophilic patients .